Resectable carcinoma developing in the remnant pancreas 7  years and 10  months after distal pancreatectomy for XXXX : report of a case.

@entity1 @entity3123 @entity788 @entity1124 @entity5 @entity1600
BACKGROUND: @entity1124 , which represents 90% of @entity788 , is one of the most lethal and aggressive @entity5 . Operative resection remains the only treatment providing prolonged survival, however, recurrence of @entity1124 occurs in up to 80% of @entity1 with @entity788 within 2  years of a potential curative resection. There are few reports of @entity3123 recurrence (primary second @entity5 ) in the remnant pancreas after pancreatectomy. CASE PRESENTATION: A 52-year-old @entity1 underwent a distal pancreatectomy for @entity788 in September 2004. Adjuvant chemotherapy was started after surgery and continued for 4  years. In March 2012, marked elevation of DUPAN-II was observed, followed by an irregular stenotic finding in the main duct. We performed an en bloc resection of the remnant pancreas in July 2012. Histologically, the @entity5 contained a second primary @entity3123 with @entity1600 . At follow-up 20  months after the second operation, the @entity1 was alive without recurrence. Fourteen cases of resectable @entity5 developing in the remnant pancreas after a pancreatectomy for @entity5 have been reported; a minority of these was identified as second @entity5 . Therefore, our @entity1 's primary second @entity5 is a rare event. CONCLUSION: The @entity1 is considered to have shown a rare, unique @entity788 recurrence. Persistent elevation of a @entity5 marker and extensive imaging led to proper diagnosis and treatment.
